Innovative Diagnostic Technology Novel Microdevices has developed a cutting-edge, portable molecular testing platform called Novel Dx that delivers laboratory-quality results in under 30 minutes, presenting significant opportunities to target healthcare providers seeking rapid, accurate diagnostics for point-of-care settings.
Recent Funding Growth The company has secured multiple rounds of funding, including a notable $5.1M Series A and subsequent follow-on investments totaling over $3.2M, indicating strong investor confidence and potential for scaling sales operations and expanding market reach.
Market Focus and Expansion With a focus on genetic pathogen detection and real-time results, Novel Microdevices is well-positioned to serve healthcare facilities, urgent care centers, and potentially international markets looking for rapid diagnostic solutions, creating targeted sales strategies for diverse customer segments.
Technology Stack and Innovation Utilizing advanced software tools such as Python, C++, and reCAPTCHA, the company demonstrates a strong commitment to technology innovation, which can be leveraged to highlight product reliability and cutting-edge features in sales pitches to technologically savvy clients.
Growth Potential and Industry Trends With a revenue range of $1M to $10M and recent investments in innovative diagnostic tools, Novel Microdevices is positioned to capitalize on ongoing trends toward decentralized, rapid testing in healthcare, offering opportunities to partners and suppliers aligned with biotech and medical device sectors.
$1B$10B
$1M$10M
$10B
$250M$500M
$10B
$250M$500MNovel Microdevices uses 8 technology products and services including RSS, Altium, jQuery, and more. Explore Novel Microdevices's tech stack below.
| Novel Microdevices Email Formats | Percentage |
| First@novelmicrodevices.com | 95% |
| FL@novelmicrodevices.com | 5% |
Biotechnology ResearchMaryland, United States11-50 Employees
Lab-quality, Clinically Actionable Results in Minutes Anywhere!
Novel Dx detects the genetic material of pathogens using Nucleic Acid Amplification techniques. These are the same methods that are utilized in large reference laboratories
Novel Dx delivers lab-quality results in under 30 minutes so patients can be tested and treated in the same visit
Company Overview
Funding & FinancialsNovel Microdevices has raised a total of $634K of funding over 7 rounds. Their latest funding round was raised on Jun 10, 2025 in the amount of $634K.
Novel Microdevices's revenue is estimated to be in the range of $10M$25M
Funding & FinancialsNovel Microdevices has raised a total of $634K of funding over 7 rounds. Their latest funding round was raised on Jun 10, 2025 in the amount of $634K.
Novel Microdevices's revenue is estimated to be in the range of $10M$25M
1-888-653-2347 
support@leadiq.com